 |
|
NIH selects LIAI for major study on allergy molecular causes and possible treatments
November 14, 2007A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract. The five-year study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, could lead to revolutionary new approaches for treating allergies based on targeting T cells, white blood cells that regulate the immune response and which are some of the principal warriors in the body's defense.
LIAI, a nonprofit organization and one of the world's leading immunology research centers, will partner on the study with clinical researchers at the University of California, San Diego (UC San Diego) and the National Jewish Medical and Research Center in Denver, Colorado. Both centers will set up human subject protocols involving allergy sufferers who will donate blood for the LIAI study. "We are excited by this research partnership that directly connects the basic immunology science that LIAI is renowned for with the clinical work in patients at these two fine institutions," said LIAI's Alessandro Sette, Ph.D., principal investigator on the allergy contract.
The study will involve 200 donors over five years and will look at 32 common allergen sources, such as trees, grasses, weeds, fungi, mites, insects and mammals. Food allergies are not part of the study.
Howard Grey, M.D., project co-investigator, said the study will push knowledge of allergies to a deeper level. "The whole field has been dominated by the analysis of the antibody response, because that's what causes many of the symptoms of the disease - the sneezing, sniffling, coughing and so forth," he said, noting that the discovery of the immunoglobulin E (IgE) antibody in 1966 by Kimishige Ishizaka, M.D., Ph.D. and his wife, Teruko Ishizaka, Ph.D., who later helped launch LIAI, revolutionized allergy research.
"Now the scientific community has the tools to take our knowledge even further by analyzing T cell responses," he said. "It seems in keeping with our history that LIAI will now lead the next step - breaking down the allergy response to its most basic molecular level."
Results from the project will be available to scientists worldwide via the NIAID's Immune Epitope Database (IEDB), the world's largest research database on how the immune system responds to infectious diseases, allergens and other agents. The database, developed by LIAI under an NIAID contract, is a public health tool designed to speed the development of vaccines and treatments by sharing important research data with scientists around the globe.
Mitchell Kronenberg, Ph.D., LIAI president & scientific director, said the project is a perfect fit with LIAI because it is developing the IEDB. In addition, allergies are a cornerstone of its immunology-focused research activities. "Many people may not be aware that the immune system plays a role in so many diseases -- from cancer to infectious diseases," he said. "Allergies are no exception, and result from inappropriate or overactive immune responses." Kronenberg said the study also enables further collaboration between LIAI, now located in the new Science Research Park at UC San Diego, and the University's researchers.
Sette said the project will map down to the level of molecules and atoms the chemical structures recognized by the immune system and which cause it to initiate an allergic reaction. "This has the potential to directly impact all people who are afflicted with allergies, because it may lead to new, more effective ways of diagnosing and treating these diseases." According to the NIAID, allergic diseases affect as many as 40 to 50 million Americans, and they are among the major causes of illness and disability in the United States. Allergies can also lead to asthma, a respiratory disorder that accounts for one-quarter of all emergency room visits in the U.S. each year.
LIAI researchers will identify the specific allergy epitopes that cause T cells to launch an attack against the allergens. Epitopes are tiny sites on a protein or other molecule that instigate a T cell response. "This opens the possibility of developing therapies around those epitopes," Grey said. "There have already been some clinical trials which are showing promise with the approach of treating patients with allergy-related epitopes. The information we're developing will provide the clinical community with the ability to try this approach with a wide variety of allergic diseases."
Currently, many allergy sufferers receive desensitization treatments, whereby the patient is given increasing doses of the substance causing allergy or allergen over a long period of time in order to develop immune tolerance to the allergen. The approach can be problematic because patients already have antibodies to the allergens, which can cause reactions, and because it is also a very lengthy process. The idea behind the epitope-based therapies is that patients could be given small pieces or epitopes from the allergen that would be able to induce immune tolerance, without instigating an antibody reaction, Sette explained. If this proves true, it could produce the same effects as the current desensitization therapies, but in a much shorter period of time, and without the allergic side effects. "You would be desensitizing the cells (with the allergy epitopes), rather than activating them," he added.
Another important aspect of the research is analyzing the effects of regulatory T cells in the allergy process. This T cell type, which has only been discovered in the last decade, appears to suppress T cell reactions to allergens, rather than cause them. "We are hoping to find specific epitopes that activate these regulatory T cells," said John Sidney, project co-investigator. "If so, we might have an extremely powerful tool for treating allergy diseases."
LIAI's project efforts will be accelerated through bioinformatics along with the use of the allergy epitope information already in the IEDB. Bioinformatics uses computer databases, algorithms and statistical techniques to analyze biological information. "We developed the IEDB and we're going to take advantage of that huge resource to improve our epitope identification algorithms based on that data," said Bjoern Peters, Ph.D., project co-investigator. "We'll use those algorithms to statistically determine which allergy epitopes are most likely to trigger a T cell response and then test those assumptions in the lab. By using bioinformatics, we will greatly speed the development of the project data."
La Jolla Institute for Allergy and Immunology
Howard Grey, M.D., project co-investigator, said the study will push knowledge of allergies to a deeper level. "The whole field has been dominated by the analysis of the antibody response, because that's what causes many of the symptoms of the disease - the sneezing, sniffling, coughing and so forth," he said, noting that the discovery of the immunoglobulin E (IgE) antibody in 1966 by Kimishige Ishizaka, M.D., Ph.D. and his wife, Teruko Ishizaka, Ph.D., who later helped launch LIAI, revolutionized allergy research.
"Now the scientific community has the tools to take our knowledge even further by analyzing T cell responses," he said. "It seems in keeping with our history that LIAI will now lead the next step - breaking down the allergy response to its most basic molecular level."
Results from the project will be available to scientists worldwide via the NIAID's Immune Epitope Database (IEDB), the world's largest research database on how the immune system responds to infectious diseases, allergens and other agents. The database, developed by LIAI under an NIAID contract, is a public health tool designed to speed the development of vaccines and treatments by sharing important research data with scientists around the globe.
Mitchell Kronenberg, Ph.D., LIAI president & scientific director, said the project is a perfect fit with LIAI because it is developing the IEDB. In addition, allergies are a cornerstone of its immunology-focused research activities. "Many people may not be aware that the immune system plays a role in so many diseases -- from cancer to infectious diseases," he said. "Allergies are no exception, and result from inappropriate or overactive immune responses." Kronenberg said the study also enables further collaboration between LIAI, now located in the new Science Research Park at UC San Diego, and the University's researchers.
Sette said the project will map down to the level of molecules and atoms the chemical structures recognized by the immune system and which cause it to initiate an allergic reaction. "This has the potential to directly impact all people who are afflicted with allergies, because it may lead to new, more effective ways of diagnosing and treating these diseases." According to the NIAID, allergic diseases affect as many as 40 to 50 million Americans, and they are among the major causes of illness and disability in the United States. Allergies can also lead to asthma, a respiratory disorder that accounts for one-quarter of all emergency room visits in the U.S. each year.
LIAI researchers will identify the specific allergy epitopes that cause T cells to launch an attack against the allergens. Epitopes are tiny sites on a protein or other molecule that instigate a T cell response. "This opens the possibility of developing therapies around those epitopes," Grey said. "There have already been some clinical trials which are showing promise with the approach of treating patients with allergy-related epitopes. The information we're developing will provide the clinical community with the ability to try this approach with a wide variety of allergic diseases."
Currently, many allergy sufferers receive desensitization treatments, whereby the patient is given increasing doses of the substance causing allergy or allergen over a long period of time in order to develop immune tolerance to the allergen. The approach can be problematic because patients already have antibodies to the allergens, which can cause reactions, and because it is also a very lengthy process. The idea behind the epitope-based therapies is that patients could be given small pieces or epitopes from the allergen that would be able to induce immune tolerance, without instigating an antibody reaction, Sette explained. If this proves true, it could produce the same effects as the current desensitization therapies, but in a much shorter period of time, and without the allergic side effects. "You would be desensitizing the cells (with the allergy epitopes), rather than activating them," he added.
Another important aspect of the research is analyzing the effects of regulatory T cells in the allergy process. This T cell type, which has only been discovered in the last decade, appears to suppress T cell reactions to allergens, rather than cause them. "We are hoping to find specific epitopes that activate these regulatory T cells," said John Sidney, project co-investigator. "If so, we might have an extremely powerful tool for treating allergy diseases."
LIAI's project efforts will be accelerated through bioinformatics along with the use of the allergy epitope information already in the IEDB. Bioinformatics uses computer databases, algorithms and statistical techniques to analyze biological information. "We developed the IEDB and we're going to take advantage of that huge resource to improve our epitope identification algorithms based on that data," said Bjoern Peters, Ph.D., project co-investigator. "We'll use those algorithms to statistically determine which allergy epitopes are most likely to trigger a T cell response and then test those assumptions in the lab. By using bioinformatics, we will greatly speed the development of the project data."
La Jolla Institute for Allergy and Immunology
Allergy News and Current Allergy Events RSSObese people with asthma have nearly 5 times greater risk of hospitalization for asthma
Obese people who have asthma are nearly five times more likely to be hospitalized for the condition than non-obese people with asthma, according to a Kaiser Permanente study published in the September issue of the Journal of Allergy and Clinical Immunology.
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
Physical and sexual abuse linked to asthma in Puerto Rican kids
Children who are physically or sexually abused are more than twice as likely to have asthma as their peers, according to a recent study of urban children in Puerto Rico. In fact, physical and sexual abuse was second only to maternal asthma in all the risk factors tested, including paternal asthma and indicators of socioeconomic status.
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine.
Trends in prescription medication sharing among reproductive-aged women
Borrowing and sharing of prescription medications is a serious medical and public health concern.
Researchers uncover molecule that keeps pathogens like salmonella in check
Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick.
Bacterial pneumonia caused most deaths in 1918 influenza pandemic
The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Many U.S. Public Schools in 'Air Pollution Danger Zone'
One in three U.S. public schools are in the "air pollution danger zone," according to new research from the University of Cincinnati (UC).
Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites
Cutaneous leishmaniasis, a disease characterized by painful skin ulcers, occurs when the parasite Leishmania major, or a related species, is transmitted to a mammalian host by the bite of an infected sand fly.
NIH scientists find a novel mechanism that controls the development of autoimmunity
Scientists at the National Institutes of Health (NIH) have found a mechanism in the immune systems of mice that can lead to the development of autoimmune disease when turned off.
More Allergy News Articles
 | Vegan Cupcakes Take Over the World: 75 Dairy-Free Recipes for Cupcakes that Rule by Isa Chandra Moskowitz, Terry Hope Romero The hosts of the vegan cooking show The Post Punk Kitchen are back with a vengeance — and this time, dessert. A companion volume to Vegan with a Vengeance, Vegan Cupcakes Take Over the World is a sweet and sassy guide to baking everyone's favorite treat without using any animal products. This unique cookbook contains over 50 recipes for cupcakes and frostings — some innovative, some... |
 | Living Well with Hypothyroidism: What Your Doctor Doesn't Tell You... That You Need to Know (Revised Edition) by Mary J. Shomon As many as one in eight women have a thyroid condition. In Living Well with Hypothyroidism, Mary Shomon outlines the most common of these--too little thyroid hormones in the body. Weight gain, depression, fatigue, and what patients call "brain fog, Brillo hair, and prune skin" result. Because the symptoms of hypothyroidism mimic so many other conditions--chronic fatigue, PMS, clinical... |
 | Healing the New Childhood Epidemics: Autism, ADHD, Asthma, and Allergies: The Groundbreaking Program for the 4-A Disorders by Kenneth Bock, Cameron Stauth Autism is an epidemic: It has spiked 1,500 percent in the last twenty years. ADHD, asthma and allergies have also skyrocketed over the same time period. One of these conditions now strikes one in every three children in America. But there is hope. Leading medical innovator Kenneth Bock, M.D., has helped change the lives of more than a thousand children, and in this important book, with a... |
 | Living Gluten-Free For Dummies (For Dummies (Health & Fitness)) by Danna Korn Includes 65 delicious gluten-free recipes plus tips on eating out Find out how easy and tasty it can be to go gluten free! If you have a wheat allergy, gluten intolerance, celiac disease, or you just want to enjoy the benefits of a diet free of wheat, barley, and rye, then this guide is for you. Author Danna Korn explains the medical problems associated with gluten and shows you... |
 | Gluten-Free Quick & Easy: From Prep to Plate Without the Fuss - 200+ Recipes for People with Food Sensitivities by Carol Fenster Wheat-free-cooking expert Carol Fenster reveals her time-saving tips and techniques to help cooks put homemade meals on the table in a flash. In Carol Fenster's gluten-free cooking classes, the most frequently asked question is "How can I get a meal on the table in the least amount of time?" So often, cooking gluten-free means spending hours in the kitchen-making everything from scratch. But... |
 | The Anti-Inflammation Diet and Recipe Book: Protect Yourself and Your Family from Heart Disease, Arthritis, Diabetes, Allergies - and More by Jessica K. Black The connection between inflammation and heart disease, arthritis, and other chronic ailments has become increasingly clear. Many food allergies and poor dietary choices over stimulate the immune system and cause inflammatory responses that erode the body’s wellness and pave the path for ill health. Based on her naturopathic practice, Jessica Black has devised a complete program for how to... |
 | Recipes for the Specific Carbohydrate Diet: The Grain-Free, Lactose-Free, Sugar-Free Solution to IBD, Celiac Disease, Autism, Cystic Fibrosis, and Other Health Conditions (Healthy Living Cookbooks) by Raman Prasad The Specific Carbohydrate Diet is a strict grain-free, lactose-free, and sucrose-free dietary regimen intended for those suffering from Crohn's disease and ulcerative colitis (both forms of IBD), celiac disease, IBS, cystic fibrosis, and autism. It is based on the work of Elaine Gottschall, who wrote Breaking the Vicious Cycle, which introduces the SCD and explains the importance of eliminating... |
 | The 125 Best Gluten-Free Recipes by Donna Washburn, Heather Butt 125 Best Gluten-Free Recipes features the type of sensational food that is typically avoided in gluten-free diets. Tasty and innovative recipes for everything from baked goods, pasta dishes, appetizers and family meals to mouth-watering desserts. These are recipes everyone can enjoy, whether they are affected by gluten intolerance or not. Here are some of the inspired gluten-free recipes you... |
 | The Inflammation Syndrome: The Complete Nutritional Program to Prevent and Reverse Heart Disease, Arthritis, Diabetes, Allergies, and Asthma by Jack Challem Early Acclaim for The Inflammation Syndrome "Challem's new book hits a home run-with the latest research on what to eat and take to defeat our real number-one cause of health problems-inflammation. It's a message of the utmost importance." -Jean Carper, New York Times bestselling author of Stop Aging Now! and Your Miracle Brain, and columnist, USA Weekend magazine "Treating and... |
 | Sinus Relief Now: The Ground-Breaking 5-Step Program for Sinus, Allergy, and AsthmaSufferers by Jordan S. Josephson Dr. Josephson's unique five-step program combines the best practices from traditional and alternative medicine to bring relief to the millions who suffer from respiratory problems. Recent research shows that many respiratory diseases are more related than previously thought. Their common, underlying cause is what Dr. Josephson terms "Chronic Airway-Digestive Inflammatory Disease" (CAID). His... |
| © 2008 BrightSurf.com |